Stock Price Quote

VYSALI PHARMACEUTICALS LTD.

NSE : NABSE : 524290ISIN CODE : INE153G01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE4.280 (0 %)
PREV CLOSE ( ) 4.28
OPEN PRICE ( ) 4.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )4.28 4.72
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1979
Management Info
- Chairman Alathur Damodaran Krishnan - Managing Director
Registered Office

Address 34/754, 755, Vysali Enclave,Kannathodath Road,Edappally,
Kochi,
Kerala-682024

Phone 0484-2339591

Email vysalipharma@yahoo.com

Website  

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
Seema , 41/427 Rajaji Road,Near Sun International,Ernakulam,Cochin
Listing : BSE

NEWS

No News Found

Financials

in Millions
QTR Sep 04 ANNUAL 04
Net Profit-24.28
Gross Profit -24.28
Operating Profit 0.96
Net Sales 197.98

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Alkem Laboratories (BSE)
peergroup  5460.90 (2.86%)
M.Cap ( in Cr)65162.93
Glaxosmithkline Phar (BSE)
peergroup  2474.50 (4.09%)
M.Cap ( in Cr)41843.29
Gland Pharma (BSE)
peergroup  1880.90 (4.76%)
M.Cap ( in Cr)30949.11
Coral Laboratories (BSE)
peergroup  451.20 (20.00%)
M.Cap ( in Cr)161.20
Pfizer (BSE)
peergroup  4567.85 (1.64%)
M.Cap ( in Cr)20815.22

Shareholding Pattern

No Data Found

About Vysali Pharmaceuticals Ltd.

Vysali Pharmaceuticals Ltd. was incorporated in the year 1979. Its today's share price is 4.28. Its current market capitalisation stands at Rs 2.32 Cr. In the latest quarter, company has reported Gross Sales of Rs. 12.06 Cr and Total Income of Rs.12.22 Cr. The company's management includes Savithri Krishnan, Alathur Damodaran Krishnan.

It is listed on the BSE with a BSE Code of 524290 , NSE with an NSE Symbol of and ISIN of INE153G01016. It's Registered office is at 34/754, 755, Vysali Enclave,Kannathodath Road,EdappallyKochi-682024, Kerala. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are K Chitrabhanu

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.